Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Fuji
Mallinckrodt
Julphar
Fish and Richardson
AstraZeneca
Argus Health
US Army
Boehringer Ingelheim

Generated: January 20, 2018

DrugPatentWatch Database Preview

DEXTROSE 70% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Dextrose 70% In Plastic Container, and when can generic versions of Dextrose 70% In Plastic Container launch?

Dextrose 70% In Plastic Container is a drug marketed by Baxter Hlthcare and Icu Medical Inc and is included in four NDAs.

The generic ingredient in DEXTROSE 70% IN PLASTIC CONTAINER is dextrose. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.
Summary for DEXTROSE 70% IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 70% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 70% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare DEXTROSE 70% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-006 Mar 26, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Icu Medical Inc DEXTROSE 70% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019893-001 Dec 26, 1989 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare DEXTROSE 70% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-003 Jul 2, 1991 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Icu Medical Inc DEXTROSE 70% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 018561-001 Mar 23, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fish and Richardson
Colorcon
Dow
Johnson and Johnson
Julphar
AstraZeneca
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot